BEIJING, June 22 Concord Medical ServicesHoldings Limited ("Concord Medical" or the "Company") (NYSE: CCM), theoperator of the largest network of radiotherapy and diagnostic imaging centersin China, today announced that it will add two new centers to its extensivenetwork by furthering its partnership with the PLA Navy General Hospital("Navy General Hospital" or "the hospital"), located in Beijing.
Concord Medical will add two new centers to the Beijing-based Navy GeneralHospital's existing facilities, bringing the total number of centers under theCompany's management at the hospital to seven. One of the centers will housean Image Guided Radiation Therapy (IGRT) system and the other center willhouse a Body Gamma Knife system. The IGRT center commenced trial operation inmid June and both centers are expected to enter into full operation in thethird quarter of 2010. Prior to these new centers, Concord Medical had beenmanaging five radiotherapy and diagnostic imaging centers at the Navy GeneralHospital, one of Concord Medical's earliest hospital partners. With theadditional centers, the hospital will further strengthen its position tobecome one of the top cancer treatment facilities in China.
"We are excited to further expand our services at the Navy GeneralHospital with the addition of two new centers. This expansion underscores ourability to grow with our hospital partners through quality service andeffective management, and puts the Navy General Hospital into one of the topcancer treatment facilities in China. In addition, furthering a longstandingpartnership symbolizes recognition of the value of our services on top of ourfinancial support to the hospital," said Dr. Jianyu Yang, director, presidentand chief executive officer of Concord Medical. "Concord Medical is on trackto achieve our goal of operating at least 200 centers by 2012. As the industryleader with the largest network of radiotherapy and diagnostic imaging centersin China, we are committed to making cancer treatment more readily availablein China and are confident that we are well positioned to benefit from afavorable market environment supported by medical reform policies andincreasing consumer demand for world-class cancer treatment."
About Concord Medical
Concord Medical operates the largest network of radiotherapy anddiagnostic imaging centers in China in terms of revenues and the total numberof centers in operation per available statistics. The Company currentlyoperates a network of more than 89 centers spanning 37 cities and 21 provincesand administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnosticimaging equipments and manages the daily operations of these centers locatedon its hospital partners' premises. The Company also provides ongoing trainingto doctors and other medical personnel in its network of centers to ensure ahigh level of clinical care for patients.
Safe Harbor Statement
This press release contains forward-looking statements. These statementsconstitute "forward-looking" statements within the meaning of Section 21E ofthe Securities Exchange Act of 1934, as amended, and as defined in the U.S.Private Securities Litigation Reform Act of 1995. These forward-lookingstatements can be identified by terminology such as "anticipate," "believe,""estimate," "expect," "forecast," "intend," "may," "plan," "project,""predict," "should" and "will" and similar expressions. These forward lookingstatements are based upon management's current views and expectations withrespect to future events and are not a guarantee of future performance.Furthermore, these statements are, by their nature, subject to a number ofrisks and uncertainties that could cause actual performance and results todiffer materially from those discussed in the forward-looking statements as aresult of a number of factors. Such factors include: the number of newradiotherapy and diagnostic imaging centers opened; the increase in the numberof patients in existing centers; the establishment of specialty cancerhospitals; changes in the healthcare industry in China, including changes inthe healthcare policies and regulations of the PRC government; andtechnological or therapeutic changes affecting the field of cancer treatmentand diagnostic imaging. Further information regarding these and other risks isincluded in the Company's filings with the U.S. Securities and ExchangeCommission at www.sec.gov. The Company does not undertake any obligation toupdate any forward-looking statement, except as required under applicable law.For investor and media inquiries please contact: China Stephanie Song Concord Medical Services Phone: +86-10-5957-5287 Email: [email protected]
Lilian Wong Brunswick Group, LLC Phone: +86-10-6566-2256 Email: [email protected]
U.S. Nicki Kahner Brunswick Group, LLC Phone: +1-212-333-3810 Email: [email protected]
SOURCE Concord Medical Services Holdings Limited